Eventide Asset Management - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 62 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$156,749,622
-19.2%
7,814,039
+13.6%
2.82%
-14.1%
Q2 2023$194,022,823
+249.6%
6,877,803
+113.1%
3.28%
+222.1%
Q1 2023$55,504,400
+27.8%
3,227,000
+49.6%
1.02%
+18.9%
Q4 2022$43,432,212
+7.7%
2,156,515
+15.9%
0.86%
+7.9%
Q3 2022$40,309,000
+42.9%
1,861,000
+85.4%
0.79%
+31.5%
Q2 2022$28,212,000
-19.7%
1,004,000
+31.9%
0.60%
+9.6%
Q1 2022$35,113,000
-21.0%
761,000
+43.9%
0.55%
-3.2%
Q4 2021$44,468,000
+26.1%
529,0000.0%0.57%
+22.2%
Q3 2021$35,253,000
+57.6%
529,000
+25.8%
0.46%
+55.0%
Q2 2021$22,365,000
-38.0%
420,400
-49.5%
0.30%
-43.9%
Q1 2021$36,100,000
-16.5%
832,0000.0%0.54%
-19.3%
Q4 2020$43,214,000
+49.9%
832,000
-8.7%
0.66%
+17.6%
Q3 2020$28,822,000
-32.2%
911,416
-0.4%
0.56%
-39.0%
Q2 2020$42,496,000914,7050.92%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,426,095$111,940,0006.63%
Paradigm Biocapital Advisors LP 287,577$13,269,0003.51%
Avidity Partners Management LP 3,176,999$146,587,0003.05%
Integral Health Asset Management, LLC 215,000$9,920,0002.58%
Matrix Capital Management Company, LP 4,349,279$200,676,0002.41%
Affinity Asset Advisors, LLC 207,500$9,574,0001.53%
Ikarian Capital, LLC 202,203$9,329,0001.23%
Ghost Tree Capital, LLC 80,000$3,691,0000.80%
Eventide Asset Management 761,000$35,113,0000.55%
Perceptive Advisors 501,509$23,140,0000.46%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders